160 related articles for article (PubMed ID: 1297639)
1. Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both medicaments.
Angrisani M; Cazzola M; Loffreda A; Losasso C; Lucarelli C; Rossi F
Int J Clin Pharmacol Res; 1992; 12(4):165-71. PubMed ID: 1297639
[TBL] [Abstract][Full Text] [Related]
2. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
3. [Tolerance and effect of short-term theophylline infusions].
Schmidt M
Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
[TBL] [Abstract][Full Text] [Related]
4. [Effect of enoxacin on theophylline pharmacokinetics].
Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
[TBL] [Abstract][Full Text] [Related]
5. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
Paterson CM; Hudson SA; Jefferson GC
J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
[TBL] [Abstract][Full Text] [Related]
6. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
7. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
[TBL] [Abstract][Full Text] [Related]
8. Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
Cazzola M; Matera MG; Paternò E; Scaglione F; Santangelo G; Rossi F
J Chemother; 1991 Aug; 3(4):240-4. PubMed ID: 1779258
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine.
Kawai H; Kokubun S; Matsumoto T; Kojima J; Onodera K
Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):179-84. PubMed ID: 10893702
[TBL] [Abstract][Full Text] [Related]
10. Adequacy of recommended aminophylline loading doses in children.
Maxwell-Rubin M; Paap CM; Godley PJ
Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
[TBL] [Abstract][Full Text] [Related]
11. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
Kowalczyk DF; Beech J; Littlejohn D
Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
[TBL] [Abstract][Full Text] [Related]
13. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
14. Early estimate of theophylline clearance during intravenous infusion.
Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
[TBL] [Abstract][Full Text] [Related]
15. The influence of enteral feedings on sustained-release theophylline absorption.
Plezia PM; Thornley SM; Kramer TH; Armstrong EP
Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
17. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
19. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
